Related Experiment Videos

Serum lipid concentration in newborns from various ethnic groups in Israel

Israel Journal of Medical Sciences
|September 1, 1978
PubMed

Insights

Serum cholesterol levels at birth are not a reliable indicator for detecting familial hypercholesterolemia early. Most hypercholesterolemic newborns normalize cholesterol by six months, regardless of ethnicity.

Area of Science:

  • Pediatric Medicine
  • Clinical Biochemistry
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL cholesterol from birth.
  • Early detection of FH is crucial for timely intervention and cardiovascular disease prevention.
  • Neonatal screening for hypercholesterolemia is a potential strategy for early FH identification.

Purpose of the Study:

  • To evaluate the predictive value of cord blood serum cholesterol for identifying infants who may have familial hypercholesterolemia.
  • To assess the persistence of hypercholesterolemia from birth through 18 months of age in a newborn cohort.

Main Methods:

  • Serum cholesterol was measured in 438 newborns' cord blood.
  • Follow-up cholesterol measurements were taken at 6 and 18 months of age.
  • Prevalence of hypercholesterolemia at birth and its persistence were analyzed across ethnic groups.

Main Results:

  • The prevalence of hypercholesterolemia at birth was 8%.
  • Of 36 infants initially identified as hypercholesterolemic, 28 (77.8%) had normalized cholesterol levels by 6 months.
  • No significant ethnic differences in cholesterol levels or persistence were observed.

Conclusions:

  • Neonatal serum cholesterol levels appear to have limited value for the early and accurate detection of familial hypercholesterolemia.
  • Transient neonatal hypercholesterolemia is common, with most cases resolving spontaneously within the first year.
  • Alternative or supplementary screening methods may be necessary for effective early FH detection in newborns.

Related Concept Videos